[et_pb_section fb_built=”1″ _builder_version=”4.18.0″ _module_preset=”default” custom_margin=”-9px|||||” custom_padding=”20px||24px|||” da_disable_devices=”off|off|off” global_colors_info=”{}” theme_builder_area=”post_content” da_is_popup=”off” da_exit_intent=”off” da_has_close=”on” da_alt_close=”off” da_dark_close=”off” da_not_modal=”on” da_is_singular=”off” da_with_loader=”off” da_has_shadow=”on”][et_pb_row _builder_version=”4.18.0″ _module_preset=”default” custom_margin=”-10px|auto||auto||” custom_padding=”6px|||||” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_column type=”4_4″ _builder_version=”4.18.0″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_text _builder_version=”4.18.0″ _module_preset=”default” text_font_size=”16px” header_2_font=”Lato||||||||” header_2_font_size=”24px” header_3_font=”Lato||||||||” header_3_text_color=”#4D8EAA” header_3_line_height=”1.4em” custom_margin=”||||false|false” custom_padding=”30px||||false|false” hover_enabled=”0″ border_width_top=”1px” border_color_top=”#4D8EAA” global_colors_info=”{}” theme_builder_area=”post_content” sticky_enabled=”0″]<\/p>\n
[\/et_pb_text][et_pb_text _builder_version=”4.18.0″ _module_preset=”default” text_font_size=”18px” custom_margin=”||40px|||” hover_enabled=”0″ global_colors_info=”{}” theme_builder_area=”post_content” sticky_enabled=”0″]<\/p>\n
BOSTON, April 21, 2022 \u2013 The Termeer Foundation, a nonprofit organization focused on connecting life science innovators and catalyzing the creation of new medicines, today announced the recipients of the 2022 Henri Termeer Transatlantic Connections Award. The awardees of the second annual honor will be recognized during a presentation at the Innovation for Health conference taking place April 21, 2022, in the Netherlands.<\/p>\n
This year\u2019s winners of the Henri Termeer Transatlantic Connections Award are: Kasper Roet, of QurAlis Corporation and Koenraad Wiedhaup, of Leyden Labs; Information about the 2021 Henri Termeer Transatlantic Connections Award winners can be found here.<\/p>\n
\u201cWe are delighted to honor the 2022 Henri Termeer Transatlantic Connections Award winners, Kasper Roet and Koenraad Wiedhaup, both of whom are deserving of this award due to their exceptional professional background and commitment to the ideals of Henri Termeer,\u201d<\/em> said Belinda Termeer, President and Co-founder of The Termeer Foundation. \u201cEven at this early stage in their careers they have shown a great capacity to combine leadership with innovation within their companies as they pursue distinct scientific paths towards developing breakthrough medicines.\u201d<\/em><\/p>\n The Henri Termeer Transatlantic Connections Award began as part of an agreement in July 2019, between the Massachusetts Office of International Trade and Investment and the Dutch Ministry of Economic Affairs and Climate Policy, which created and signed a Memorandum of Understanding laying the basis for a Massachusetts \u2013 Netherlands Transatlantic Life Sciences Partnership. The signatories included Top Sector Life Sciences & Health (Health-Holland), MassBio, HollandBIO and the Henri A. Termeer Tribute Committee; all of whom agreed to provide support and organize activities to promote trans-Atlantic collaboration between the two biotechnology ecosystems.<\/p>\n \u201cThe Transatlantic Connections Award creates significant opportunities for its recipients to network, learn and possibly collaborate with life science professionals in two of the most important life science sectors,\u201d<\/em> said Hans Schikan, board member of Health-Holland and a member of the Henri Termeer Transatlantic Connections Award Steering Committee. \u201cOver the course of the next year as Award recipients and beyond as Termeer Fellows, this year\u2019s winners will be presented with a variety of chances to enhance their knowledge of the global life science sector and plant the seeds for future company success.\u201d<\/em><\/p>\n Each year, the Termeer Foundation and Health-Holland selects two emerging life science entrepreneurs, one in Massachusetts and one in the Netherlands, who are leading innovative biomedical research activities, and whose programs have the potential to strengthen transatlantic relations between the two life science regions. Candidates are selected based on their initial entrepreneurial success in establishing a life science company that meets certain scientific and financial criteria, exhibit a strong interest in mentoring other young entrepreneurs, and possess a willingness for additional involvement in Termeer Foundation programs. Awardees also receive Fellowship status within The Termeer Foundation, which includes access to experienced healthcare mentors, networking with fellow peer entrepreneurs, and recognition at the annual Termeer Fellows Celebration. Recipients are invited to spend a week visiting their fellow awardee\u2019s company and local biotechnology sector, and to participate in additional learning, networking and cultural events in that location.<\/p>\n \u201cWhen QurAlis was established, we recognized that even at an early stage developing medicines to treat neurodegenerative diseases has no borders or geographical limitations,\u201d<\/em> said Kasper Roet, Co-founder and Chief Executive Officer, QurAlis. \u201cBeing selected to receive the Transatlantic Connections Award is not only an honor, but an excellent platform from which to create those all-important relationships outside our sector.\u201d<\/em><\/p>\n The Greater Boston and Netherlands biotechnology sectors represent two of the world\u2019s prolific global biomedical research centers. Boston and Cambridge is home to approximately 1,400 biotechnology companies; ranging from small, emerging start-ups to larger, more established biopharmaceutical companies. Cambridge\u2019s Kendall Square is the heart of this sector and holds a large concentration of life science companies, with over 120 located within the Square\u2019s small footprint. The highly collaborative Dutch Life Sciences & Health community includes 3,100 R&D life sciences companies, 420 biopharmaceutical companies, 65,000 employees in pharmaceuticals and a 4.7-billion-euro medtech market. Life Sciences businesses in the Netherlands profit from countless opportunities for growth and collaboration.<\/p>\n \u201cTo receive The Termeer Transatlantic Connections Award and the recognition of our company\u2019s vision is a wonderful compliment to the work we have done, thus far,\u201d<\/em> said Koenraad Wiedhaup, Founder and Chief Executive Officer, Leyden Labs. \u201cI am excited to become a part of the established link between the Massachusetts and Netherlands biotech ecosystems created by Henri Termeer and look forward to participating in the upcoming programs with my fellow award honoree.\u201d<\/em><\/p>\n [\/et_pb_text][et_pb_text _builder_version=”4.18.0″ _module_preset=”default” text_font_size=”16px” header_2_font=”Lato||||||||” header_2_font_size=”24px” custom_margin=”||||false|false” custom_padding=”30px||||false|false” border_width_top=”1px” border_color_top=”#4D8EAA” global_colors_info=”{}” theme_builder_area=”post_content” global_module=”1541″ saved_tabs=”all”]<\/p>\n Building on the bold legacy of Henri Termeer, who pioneered groundbreaking treatments for rare diseases, The Termeer Foundation connects life science innovators and catalyzes the creation of new medicines. The Foundation\u2019s network of emerging and established healthcare innovators cultivates tomorrow\u2019s leaders and leverages their collective expertise to solve complex problems in drug development and accessibility. The Foundation also integrates its network with academic institutions, nonprofits, regulatory agencies and other organizations across the global healthcare ecosystem to provide expert counsel, stimulate innovation, eliminate barriers to progress, and ultimately connect the world of healthcare until every patient has a cure. Visit us at www.termeerfoundation.org<\/a> or on LinkedIn @TermeerFoundation<\/a>.<\/p>\nAbout The Termeer Foundation<\/h2>\n